Pulmonary Embolism: Controversies in Therapeutic Management

The use of an inferior vena cava (IVC) filler in the management of venous thromboembolism remains controversial. Placement of an IVC titter may be considered a possible choice in patients with significant pulmonary embolism (PE) and deep vein thrombosis (DVT) to prevent subsequent embolic events. Ho...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 201; no. 2; pp. 240 - 242
Main Authors Male, Eneida, Alashram, Rami, Patel, Maulin, Mamary, Albert J, Rali, Parth
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 15.01.2020
Subjects
Anticoagulants
Humans
Lung diseases
Mortality
Pulmonary Embolism
Pulmonary embolisms
Thromboembolism
Thrombolytic Therapy
Venous Thrombosis
Online AccessGet full text

Cover

More Information
Summary:The use of an inferior vena cava (IVC) filler in the management of venous thromboembolism remains controversial. Placement of an IVC titter may be considered a possible choice in patients with significant pulmonary embolism (PE) and deep vein thrombosis (DVT) to prevent subsequent embolic events. However, this choice has to be weighed against a lack of mortality benefit, increased risk of DVTs, vascular injuries caused by the filter, and medicolegal issues that arise when the filters are not retrieved in a timely manner. Using all-payer administrative data from three states, Turner and colleagues conducted a retrospective cohort study and identified adult patients with DVT and/or Pt and contraindications to anticoagulation, and studied whether IVC filter placement was associated with a difference in 30-day mortality.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:1073-449X
1535-4970
DOI:10.1164/rccm.201812-2357RR